Zura Bio Ltd. (ZURA)
4.04
-0.12
(-2.88%)
USD |
NASDAQ |
Sep 25, 16:00
4.045
0.00 (0.00%)
After-Hours: 19:59
Zura Bio Net Income (Quarterly) : -26.30M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.30M |
| March 31, 2026 | -24.22M |
| December 31, 2025 | -17.18M |
| September 30, 2025 | -18.04M |
| June 30, 2025 | -15.99M |
| March 31, 2025 | -17.44M |
| December 31, 2024 | -13.62M |
| September 30, 2024 | -20.70M |
| June 30, 2024 | -10.33M |
| March 31, 2024 | -7.747M |
| December 31, 2023 | -8.473M |
| Date | Value |
|---|---|
| September 30, 2023 | -8.27M |
| June 30, 2023 | -34.02M |
| March 31, 2023 | -9.795M |
| December 31, 2022 | 13.40M |
| September 30, 2022 | -1.102M |
| June 30, 2022 | -0.925M |
| March 31, 2022 | -7.819M |
| December 31, 2021 | 0.8176M |
| September 30, 2021 | 5.787M |
| June 30, 2021 | -0.0191M |
| March 31, 2021 | -0.033M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| NovelStem International Corp. | -0.0858M |
| Brainstorm Cell Therapeutics, Inc. | -3.855M |
| Summit Therapeutics, Inc. | -215.70M |
| Kezar Life Sciences, Inc. | -5.756M |
| Protara Therapeutics, Inc. | -21.67M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 26.30M |
| EPS Diluted (Quarterly) | -0.2074 |
| Enterprise Value | 180.37M |
| Earnings Yield | -31.14% |
| Normalized Earnings Yield | -31.14 |